Homocysteine, Homocysteine Thiolactone and Protein N-Homocysteinylation in Disorders of Human Pregnancy and Reproduction: Focus on Pre-Eclampsia

Homocysteine (Hcy) is a non-proteinogenic amino acid formed as a normal intermediate of methionine metabolism. Elevated circulating Hcy concentrations are associated with oxidative stress and endothelial dysfunction, and hyperhomocysteinaemia has been associated with cardiovascular diseases. Normal total plasma concentrations of Hcy are considered lie in the range 5-15 mmol/L, though many consider levels above 10 mmol/L to constitute hyperhomocysteinaemia. One potential mechanism linking elevated Hcy to adverse effects is its conversion to a thiolactone (HTL) that can react with the e-amino groups of lysine residues in essentially any protein, resulting in protein N-homocysteinylation. Hcy levels should thus be kept low (but not eliminated as it is required for cysteine production). Plasma Hcy levels are influenced by genetic variation in enzymes involved in one-carbon and transsulphuration metabolism, particularly in low-activity alleles of methylene tetrahydrofolate reductase (MTHFR) and of cystathionine b-synthase (CBS), as well as by the status of B vitamins including folate (B9), and/or B12, and/or pyridoxine (B6), and/or riboflavin (B2). We here review the extensive evidence linking Hcy, HTL and protein N-homocysteinylation with disorders of pregnancy and reproduction, with a particular focus on pre-eclampsia, where oxidative stress and endothelial dysfunction are prominent and established features. Collectively, the evidence supports the importance of ensuring adequate B vitamin status, especially folate, before and during pregnancy, as well as suitable antioxidants. Interventions targeting Hcy metabolism or associated oxidative stress may offer safe and promising approaches to the prevention and treatment of pregnancy complications, warranting further clinical investigation.

Authors

Publication Details

Journal
Preprints.org
Published
2026-11-18
DOI
https://doi.org/10.20944/preprints202611.1772.v1
Primary Topic
Folate and B Vitamins Research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Homocysteine, Homocysteine Thiolactone and Protein N-Homocysteinylation in Disorders of Human Pregnancy and Reproduction: Focus on Pre-Eclampsia

Louise C. Kenny, Abi Merriel, J. Bernadette Moore, Douglas Bruce Kell et al.
Preprints.org
Folate and B Vitamins Research
preprint

Homocysteine, Homocysteine Thiolactone and Protein N-Homocysteinylation in Disorders of Human Pregnancy and Reproduction: Focus on Pre-Eclampsia

Louise C. Kenny, Abi Merriel, J. Bernadette Moore, Douglas Bruce Kell, Catriona John Waitt
preprint en

Abstract

Homocysteine (Hcy) is a non-proteinogenic amino acid formed as a normal intermediate of methionine metabolism. Elevated circulating Hcy concentrations are associated with oxidative stress and endothelial dysfunction, and hyperhomocysteinaemia has been associated with cardiovascular diseases. Normal total plasma concentrations of Hcy are considered lie in the range 5-15 mmol/L, though many consider levels above 10 mmol/L to constitute hyperhomocysteinaemia. One potential mechanism linking elevated Hcy to adverse effects is its conversion to a thiolactone (HTL) that can react with the e-amino groups of lysine residues in essentially any protein, resulting in protein N-homocysteinylation. Hcy levels should thus be kept low (but not eliminated as it is required for cysteine production). Plasma Hcy levels are influenced by genetic variation in enzymes involved in one-carbon and transsulphuration metabolism, particularly in low-activity alleles of methylene tetrahydrofolate reductase (MTHFR) and of cystathionine b-synthase (CBS), as well as by the status of B vitamins including folate (B9), and/or B12, and/or pyridoxine (B6), and/or riboflavin (B2). We here review the extensive evidence linking Hcy, HTL and protein N-homocysteinylation with disorders of pregnancy and reproduction, with a particular focus on pre-eclampsia, where oxidative stress and endothelial dysfunction are prominent and established features. Collectively, the evidence supports the importance of ensuring adequate B vitamin status, especially folate, before and during pregnancy, as well as suitable antioxidants. Interventions targeting Hcy metabolism or associated oxidative stress may offer safe and promising approaches to the prevention and treatment of pregnancy complications, warranting further clinical investigation.

Preprints.org
Folate and B Vitamins Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon